Can Aspirin increase survival rates in cancer patients? Can the drug also prevent the spread of cancer to other parts of the body? Studies suggest so. Listen in to Priyanka Sharma.

Gravitas: Studies suggest Aspirin can increase survival rates in cancer patients

A research has revealed that taking the over-the-counter painkiller aspirin has potential benefits that outweigh the side effects. Researchers at Cardiff University reviewed the earlier studies of aspirin and cancer and published the findings in the journal Open Biology.

As per Times UK, they found direct evidence that patients who took aspirin survived longer and also presented the biological mechanisms that might explain the effect. These include “reductions by aspirin in cancer-related inflammation, abnormal clotting and abnormal blood vessel growth, and enhancement in cellular repair”.

Also Read |&nbsp;<a href="https://www.wionews.com/world/scientists-develop-microrobots-that-surround-a-cancer-cell-and-kill-it-498833">Scientists develop microrobots that surround a cancer cell and kill it</a>

The researchers said that several studies suggest that aspirin could boost survival chances by about 20 per cent across different cancers. Some studies also point out a reduction of about a third in the spread of cancer.

However, they stressed the importance of further evidence since different trials threw up varied results. They said&nbsp;that there “appears to be an impressive harmony between the biological effects of aspirin on mechanisms relevant to cancer, and the effects of aspirin on clinical outcomes in cancer”.

Going by the results, they have deemed aspirin as a "relatively safe drug", especially among cancer patients.

Sam Godfrey, head of research information at Cancer Research UK, told Times UK, “This review examines what we know so far about the fascinating effect that aspirin has on the biology of cancer and how it might be helping to increase survival and prevent cancer from spreading to other parts of the body. But we still need more clinical research to establish how effective aspirin is, what patients will benefit from taking the drug and how much they should take and for how long."

Also Read |&nbsp;<a href="https://www.wionews.com/science/this-single-blood-test-can-detect-50-types-of-cancer-before-symptoms-emerge-393864">This single blood test can detect 50 types of cancer before symptoms emerge</a>

“To help answer some of these questions, Cancer Research UK is funding Add-Aspirin, the world’s largest clinical trial studying if aspirin can prevent certain types of cancer from coming back.”

Around 11,000 patients from the UK, Ireland and India are expected to participate&nbsp;in the new trial. These patients would have undergone treatment for early-stage cancer to see whether regular aspirin use can prevent recurrence or death.&nbsp;

(With inputs from agencies)

&nbsp;

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

A research has revealed that taking the over-the-counter painkiller aspirin has potential benefits that outweigh the side effects. Researchers at Cardiff University reviewed the earlier studies of aspirin and cancer and published the findings in the journal Open Biology.

A research has revealed that taking the over-the-counter painkiller aspirin has potential benefits that outweigh the side effects. Researchers at Cardiff University reviewed the earlier studies of aspirin and cancer and published the findings in the journal Open Biology. As per Times UK, they found direct evidence that patients who took aspirin survived longer and also presented the biological mechanisms that might explain the effect. These include “reductions by aspirin in cancer-related inflammation, abnormal clotting and abnormal blood vessel growth, and enhancement in cellular repair”. Also Read | Scientists develop microrobots that surround a cancer cell and kill it The researchers said that several studies suggest that aspirin could boost survival chances by about 20 per cent across different cancers. Some studies also point out a reduction of about a third in the spread of cancer. However, they stressed the importance of further evidence since different trials threw up varied results. They said that there “appears to be an impressive harmony between the biological effects of aspirin on mechanisms relevant to cancer, and the effects of aspirin on clinical outcomes in cancer”. Going by the results, they have deemed aspirin as a "relatively safe drug", especially among cancer patients. Sam Godfrey, head of research information at Cancer Research UK, told Times UK, “This review examines what we know so far about the fascinating effect that aspirin has on the biology of cancer and how it might be helping to increase survival and prevent cancer from spreading to other parts of the body. But we still need more clinical research to establish how effective aspirin is, what patients will benefit from taking the drug and how much they should take and for how long." Also Read | This single blood test can detect 50 types of cancer before symptoms emerge “To help answer some of these questions, Cancer Research UK is funding Add-Aspirin, the world’s largest clinical trial studying if aspirin can prevent certain types of cancer from coming back.” Around 11,000 patients from the UK, Ireland and India are expected to participate in the new trial. These patients would have undergone treatment for early-stage cancer to see whether regular aspirin use can prevent recurrence or death. (With inputs from agencies)

Aspirin found to boost survival rate in cancer patients in new study

A new report released by the United States Preventive Services Task Force (USPSTF) on Tuesday (April 26) states taking low-dose aspirin on regular basis has little to no benefit for most adults suffering from heart problems.

In fact, scientists believe that it can lead to internal bleeding inside the stomach or brain as people get older.

Heart attacks are responsible for one in four deaths in the United States making them the lead cause of mortality.

Every year, at least 6,10,000 people experience their first stroke in the US while nearly 6,05,000 suffer their first myocardial infarction.

<a href="https://www.wionews.com/world/aspirin-may-hold-the-key-to-battling-a-rare-form-of-breast-cancer-408370">Also read |&nbsp;Aspirin may hold the key to battling a rare form of breast cancer</a>

The USPSTF conducted the study on adults who were older than 40 years and did not have any symptoms of Cardiovascular disease (CVD).

The people tested between the age of 40 to 50 years had a 10 per cent or greater 10-year CVD risk which has a small net benefit.

The task force's updated guidelines recommend against starting low-dose aspirin use for the prevention of heart attack in adults who are above 60-years-old.

According to cardiologist Steven Nissen, “If you’re taking an aspirin a day and you get in a motor vehicle accident, you’re going to bleed more.”

He is the chief academic officer of the Heart, Vascular, and Thoracic Institute at the Cleveland Clinic.

<a href="https://www.wionews.com/world/do-not-administer-aspirin-ibuprofen-and-paracetamol-for-chronic-pain-urges-new-uk-health-report-to-doctors-318025">Also read |&nbsp;Do not administer aspirin, ibuprofen and paracetamol for chronic pain, urges new UK health report to doctors</a>

“Group by group, bit by bit, people have come around to the idea that the risks are about equivalent to its benefits for most people,” he told CNN.

His opinion was reiterated by Dr. James Cireddu, medical director of the Harrington Heart and Vascular Institute at University Hospitals Bedford Medical Centre, who said "The more data we get, the more we're seeing that even though the risk of coronary disease and heart attack goes up as you get older, the risk of bleeding seems to be going up even faster."

Watch WION's live TV here:

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

"When you look at all the studies that have been done recently, it seems that the modest benefit of aspirin and otherwise low-risk individuals is generally negated by the increase in long-term GI problems, bleeding with aspirin," said co-chair of the committee that released guidelines on the same topic by American College of Cardiology or American Heart Association.

"While we said it could be considered to give aspirin to someone who never had a heart attack or stroke, that should probably be the last of the things on the priority list," he added.

In its previous guidelines that were released in 2016, the USPSTF had&nbsp;it recommended that people in their 50s, who are at risk for heart disease, should take baby aspirin to prevent both cardiovascular disease and colon cancer.

(With inputs from agencies)

A new report released by the United States Preventive Services Task Force (USPSTF) on Tuesday (April 26) states taking low-dose aspirin on regular basis has little to no benefit for most adults suffering from heart problems.

A new report released by the United States Preventive Services Task Force (USPSTF) on Tuesday (April 26) states taking low-dose aspirin on regular basis has little to no benefit for most adults suffering from heart problems. In fact, scientists believe that it can lead to internal bleeding inside the stomach or brain as people get older. Heart attacks are responsible for one in four deaths in the United States making them the lead cause of mortality. Every year, at least 6,10,000 people experience their first stroke in the US while nearly 6,05,000 suffer their first myocardial infarction. Also read | Aspirin may hold the key to battling a rare form of breast cancer The USPSTF conducted the study on adults who were older than 40 years and did not have any symptoms of Cardiovascular disease (CVD). The people tested between the age of 40 to 50 years had a 10 per cent or greater 10-year CVD risk which has a small net benefit. The task force's updated guidelines recommend against starting low-dose aspirin use for the prevention of heart attack in adults who are above 60-years-old. According to cardiologist Steven Nissen, “If you’re taking an aspirin a day and you get in a motor vehicle accident, you’re going to bleed more.” He is the chief academic officer of the Heart, Vascular, and Thoracic Institute at the Cleveland Clinic. Also read | Do not administer aspirin, ibuprofen and paracetamol for chronic pain, urges new UK health report to doctors “Group by group, bit by bit, people have come around to the idea that the risks are about equivalent to its benefits for most people,” he told CNN. His opinion was reiterated by Dr. James Cireddu, medical director of the Harrington Heart and Vascular Institute at University Hospitals Bedford Medical Centre, who said "The more data we get, the more we're seeing that even though the risk of coronary disease and heart attack goes up as you get older, the risk of bleeding seems to be going up even faster." Watch WION's live TV here: "When you look at all the studies that have been done recently, it seems that the modest benefit of aspirin and otherwise low-risk individuals is generally negated by the increase in long-term GI problems, bleeding with aspirin," said co-chair of the committee that released guidelines on the same topic by American College of Cardiology or American Heart Association. "While we said it could be considered to give aspirin to someone who never had a heart attack or stroke, that should probably be the last of the things on the priority list," he added. In its previous guidelines that were released in 2016, the USPSTF had it recommended that people in their 50s, who are at risk for heart disease, should take baby aspirin to prevent both cardiovascular disease and colon cancer. (With inputs from agencies)

Taking low-dose aspirin on regular basis does not prevent heart attack: Report

Researchers are testing the efficacy of aspirin in treating aggressive forms of breast cancer.

For patients with triple-negative breast cancer, researchers hope the widely available and cheap drug can be combined with immunotherapy.

Also read |&nbsp;<a href="https://www.wionews.com/science/dont-worry-about-covid-22-here-are-misconceptions-about-it-408319" hreflang="en">Don't worry about Covid-22: Here are misconceptions about it</a>

This study is funded by the Breast Cancer Now Catalyst Program, an organisation that aims to increase the speed of progress in research by fostering innovation and facilitating collaboration. This study is an attempt to determine if aspirin increases the sensitivity of such patients' tumours to immunotherapy.

As part of the study, headed by Dr Anne Armstrong of the Christie NHS foundation trust in Manchester, the drug avelumab will be administered before patients undergo surgery and chemotherapy both with and without aspirin.

Breast Cancer Now claims that triple-negative breast cancer is a rarer but often more aggressive form of breast cancer disproportionately affecting young women and black women.

Also read |&nbsp;<a href="https://www.wionews.com/science/autovacc-thai-experts-develop-robotic-arm-to-save-every-drop-of-covid-vaccine-408259" hreflang="en">'AutoVacc': Thai experts develop robotic arm to save every drop of Covid vaccine</a>

Armstrong says that earlier research suggests that aspirin makes immunotherapy more effective by stopping cancer cells from producing substances that lead to weakened immunity.

If used in conjunction with immunotherapy, anti-inflammatory drugs such as aspirin could increase their effectiveness. A drug like aspirin is a great candidate for clinical trials since it is readily available and cheap to produce, she added.

Simon Vincent, the director of research, support, and advocacy at Breast Cancer Now, stated that 8,000 women are diagnosed with triple-negative breast cancer every year in the UK. He noted that this situation needs to be addressed immediately.

Pfizer, the pharmaceutical firm, provided Breast Cancer Now with funding through a grant and gave its researchers access to several Pfizer medicines, according to Breast Cancer Now.

Researchers are testing the efficacy of aspirin in treating aggressive forms of breast cancer. For patients with triple-negative breast cancer, researchers hope the widely available and cheap drug can be combined with immunotherapy.

Researchers are testing the efficacy of aspirin in treating aggressive forms of breast cancer. For patients with triple-negative breast cancer, researchers hope the widely available and cheap drug can be combined with immunotherapy. Also read | Don't worry about Covid-22: Here are misconceptions about it This study is funded by the Breast Cancer Now Catalyst Program, an organisation that aims to increase the speed of progress in research by fostering innovation and facilitating collaboration. This study is an attempt to determine if aspirin increases the sensitivity of such patients' tumours to immunotherapy. As part of the study, headed by Dr Anne Armstrong of the Christie NHS foundation trust in Manchester, the drug avelumab will be administered before patients undergo surgery and chemotherapy both with and without aspirin. Breast Cancer Now claims that triple-negative breast cancer is a rarer but often more aggressive form of breast cancer disproportionately affecting young women and black women. Also read | 'AutoVacc': Thai experts develop robotic arm to save every drop of Covid vaccine Armstrong says that earlier research suggests that aspirin makes immunotherapy more effective by stopping cancer cells from producing substances that lead to weakened immunity. If used in conjunction with immunotherapy, anti-inflammatory drugs such as aspirin could increase their effectiveness. A drug like aspirin is a great candidate for clinical trials since it is readily available and cheap to produce, she added. Simon Vincent, the director of research, support, and advocacy at Breast Cancer Now, stated that 8,000 women are diagnosed with triple-negative breast cancer every year in the UK. He noted that this situation needs to be addressed immediately. Pfizer, the pharmaceutical firm, provided Breast Cancer Now with funding through a grant and gave its researchers access to several Pfizer medicines, according to Breast Cancer Now.

Aspirin may hold the key to battling a rare form of breast cancer

According to UK's National Institute for Health and Care Excellence(NICE), painkillers such as aspirin, ibuprofen and paracetamol do more than good.

<a href="https://www.wionews.com/health-and-wellness/genetics-act-as-basis-for-anxiety-study-273326">Also Read:&nbsp;Genetics foundation of anxiety and depression: Study</a>

The report urged doctors not to prescribe the drug to those who have been suffering from chronic pain.

The report said that there is "no evidence" that the drug made any difference to the patient's health while adding it could cause an addiction to the drug.&nbsp;

The NICE report stated that at least one third to half of the UK population suffered from chronic pain which led to depression. However, it asked doctors not to give patients aspirin or ibuprofen.

The report said that although some antidepressants can be considered but other drugs such as corticosteroid, &nbsp;antipsychotics, gabapentinoids, ketamine should be administered to patients suffering from chronic pain.

NICE further claimed that it was "inappropriate" for doctors to give normal painkillers to patients. The report claimed that the painkillers showed no sighs it made any difference to the patient's "quality of life, pain or psychological distress".

The committee asserted that "not commenting on these medicines could result in their continued use in practice, which would be inappropriate given the lack of evidence and possible harms, so they recommended against the use of these treatments."

The report recommended exercise, psychological therapy and even acupuncture can help resolve pain while it not just improved quality of life but also reduced pain among patients in several case studies. &nbsp;

The draft report published on Monday is under public consideration until August 14. 
&nbsp;

According to UK's National Institute for Health and Care Excellence(NICE), painkillers such as aspirin, ibuprofen and paracetamol do more than good. Also Read: Genetics foundation of anxiety and depression: Study The report urged doctors not to prescribe the drug to those who have been suffering from chronic pain.

According to UK's National Institute for Health and Care Excellence(NICE), painkillers such as aspirin, ibuprofen and paracetamol do more than good. Also Read: Genetics foundation of anxiety and depression: Study The report urged doctors not to prescribe the drug to those who have been suffering from chronic pain. The report said that there is "no evidence" that the drug made any difference to the patient's health while adding it could cause an addiction to the drug. The NICE report stated that at least one third to half of the UK population suffered from chronic pain which led to depression. However, it asked doctors not to give patients aspirin or ibuprofen. The report said that although some antidepressants can be considered but other drugs such as corticosteroid, antipsychotics, gabapentinoids, ketamine should be administered to patients suffering from chronic pain. NICE further claimed that it was "inappropriate" for doctors to give normal painkillers to patients. The report claimed that the painkillers showed no sighs it made any difference to the patient's "quality of life, pain or psychological distress". The committee asserted that "not commenting on these medicines could result in their continued use in practice, which would be inappropriate given the lack of evidence and possible harms, so they recommended against the use of these treatments." The report recommended exercise, psychological therapy and even acupuncture can help resolve pain while it not just improved quality of life but also reduced pain among patients in several case studies. The draft report published on Monday is under public consideration until August 14.

Do not administer aspirin, ibuprofen and paracetamol for chronic pain, urges new UK health report to doctors

aspirin

Aspirin, News on Aspirin, stories on Aspirin, articles on Aspirin, Aspirin stories at Wion, Aspirin news, Aspirin latest news